Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy

2021 ◽  
Author(s):  
Xueqian Zuo ◽  
Haibo Zhao ◽  
Dan Li
Keyword(s):  
Ovarian Cancer ◽  
Personalized Therapy ◽  
Inhibitor Selectivity

scholarly journals New cell line models for the development of personalized therapy for high grade serous ovarian cancer

2017 ◽  
Vol 28 ◽  
pp. vii15-vii16
Author(s):  
D. Castillo-Tong ◽  
I. Von Der Decken ◽  
S. Pfaffinger ◽  
A. Wolf ◽  
C. Kreuzinger ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cell Line ◽  
Personalized Therapy ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
New Cell Line

33. Tumor testing of DNA repair genes in high grade serous ovarian cancer (HGSOC); a potential tool for personalized therapy

2020 ◽  
Vol 244 ◽  
pp. 13
Author(s):  
Elizabeth McCready ◽  
Darci Butcher ◽  
Crystal Woodside ◽  
Dorsa Kord ◽  
Mona Lisa Sur ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Dna Repair ◽  
Personalized Therapy ◽  
High Grade ◽  
Dna Repair Genes ◽  
Serous Ovarian Cancer ◽  
Repair Genes ◽  
Potential Tool

Abstract 4156: Molecular profiling of ovarian cancer by targeted proteomics to inform personalized therapy

2020 ◽  
Author(s):  
Sheeno P. Thyparambil ◽  
Wei-Li Liao ◽  
Eunkyung An ◽  
Anuja Bhalkikar ◽  
Thomas Guiel ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Molecular Profiling ◽  
Personalized Therapy ◽  
Targeted Proteomics

Impact of extended cycles of chemotherapy on survival outcome in recurrent epithelial ovarian cancer

2020 ◽  
Vol 159 ◽  
pp. 346-347
Author(s):  
W.Y. Hwang ◽  
S.I. Kim ◽  
M. Lee ◽  
K. Kim ◽  
J.H. No ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Survival Outcome
Sign in / Sign up

Export Citation Format

Share Document